Open AccessPlacental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose Aspirin
Author(s) -
Scott W. Walsh,
Daniel T. Reep,
Shamsul Alam,
Sonya L. Washington,
Marwah Al Dulaimi,
Stephanie M Lee,
Edward Springel,
Jerome F. Strauss,
Daniel Stephenson,
Charles E. Chalfant
Publication year - 2020
Publication title -
reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.927
H-Index - 77
eISSN - 1933-7205
pISSN - 1933-7191
DOI - 10.1007/s43032-020-00234-2
Subject(s) - sphingolipid , preeclampsia , aspirin , lipid signaling , medicine , reproductive medicine , andrology , eicosanoid , pregnancy , endocrinology , obstetrics , chemistry , biology , arachidonic acid , microbiology and biotechnology , biochemistry , inflammation , enzyme , genetics
Low-dose aspirin, which selectively inhibits thromboxane synthesis, is now standard of care for the prevention of preeclampsia in at risk women, but some women still develop preeclampsia despite an aspirin regimen. To explore the "aspirin failures," we undertook a comprehensive evaluation of placental lipids to determine if abnormalities in non-aspirin sensitive lipids might help explain why some women on low-dose aspirin develop preeclampsia. We studied placentas from women with normal pregnancies and women with preeclampsia. Placental villous explants were cultured and media analyzed by mass spectrometry for aspirin-sensitive and non-aspirin-sensitive lipids. In women who developed severe preeclampsia and delivered preterm, there were significant elevations in non-aspirin-sensitive lipids with biologic actions that could cause preeclampsia. There were significant increases in 15- and 20-hydroxyeicosatetraenoic acids and sphingolipids: D-e-C 18:0 ceramide, D-e-C 18:0 sphingomyelin, D-e-sphingosine-1-phosphate, and D-e-sphinganine-1-phosphate. With regard to lipids sensitive to aspirin, there was no difference in placental production of thromboxane or prostacyclin, but prostaglandins were lower. There was no difference for isoprostanes, but surprisingly, anti-inflammatory omega 3 and 6 PUFAs were increased. In total, 10 of 30 eicosanoids and 5 of 42 sphingolipids were abnormal in women with severe early onset preeclampsia. Lipid changes in women with mild preeclampsia who delivered at term were of lesser magnitude with few significant differences. The placenta produces many aspirin-sensitive and non-aspirin-sensitive lipids. Abnormalities in eicosanoids and sphingolipids not sensitive to aspirin might explain why some aspirin-treated women develop preeclampsia.